117 related articles for article (PubMed ID: 35437033)
1. Expression of Cytochrome P450 Enzymes in Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Possible Role in Carcinogenesis and Treatment Response.
Torres-Zárate C; Vences-Mejía A; Espinosa-Aguirre JJ; Díaz-Díaz E; Palacios-Acosta JM; Cárdenas-Cardós R; Hernández-Arrazola D; Shalkow-Klincovstein J; Jurado RR; Santes-Palacios R; Molina-Ortiz D
Int J Toxicol; 2022; 41(3):234-242. PubMed ID: 35437033
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.
Molina-Ortiz D; Camacho-Carranza R; González-Zamora JF; Shalkow-Kalincovstein J; Cárdenas-Cardós R; Ností-Palacios R; Vences-Mejía A
PLoS One; 2014; 9(4):e93261. PubMed ID: 24699256
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
4. MDR1 not CYP3A4 gene expression is the predominant mechanism of innate drug resistance in pediatric soft tissue sarcoma patients.
Molina-Ortiz D; Torres-Zárate C; Cárdenas-Cardós R; Palacios-Acosta JM; Hernández-Arrazola D; Shalkow-Klincovstein J; Díaz-Díaz E; Vences-Mejía A
Cancer Biomark; 2018; 22(2):317-324. PubMed ID: 29689707
[TBL] [Abstract][Full Text] [Related]
5. Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity.
Rao PS; Kumar S
Alcohol Clin Exp Res; 2016 Jan; 40(1):73-82. PubMed ID: 26727525
[TBL] [Abstract][Full Text] [Related]
6. Characterization of cytochrome P450 expression in human oesophageal mucosa.
Lechevrel M; Casson AG; Wolf CR; Hardie LJ; Flinterman MB; Montesano R; Wild CP
Carcinogenesis; 1999 Feb; 20(2):243-8. PubMed ID: 10069460
[TBL] [Abstract][Full Text] [Related]
7. Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.
Kumar S; Sinha N; Gerth KA; Rahman MA; Yallapu MM; Midde NM
Biochem Biophys Res Commun; 2017 Sep; 491(3):675-680. PubMed ID: 28756226
[TBL] [Abstract][Full Text] [Related]
8. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.
Modugno F; Knoll C; Kanbour-Shakir A; Romkes M
Breast Cancer Res Treat; 2003 Dec; 82(3):191-7. PubMed ID: 14703066
[TBL] [Abstract][Full Text] [Related]
9. Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro.
Pan Y; Tiong KH; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
J Nat Med; 2014 Apr; 68(2):402-6. PubMed ID: 23881640
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
11. Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes.
Chen H; Zhang X; Feng Y; Rui W; Shi Z; Wu L
Mol Med Rep; 2014 Sep; 10(3):1355-62. PubMed ID: 24939038
[TBL] [Abstract][Full Text] [Related]
12. Expression of cytochrome P450 enzymes CYP1A1, CYP1B1, CYP2E1 and CYP4B1 in cultured transitional cells from specimens of the human urinary tract and from urinary sediments.
Roos PH; Belik R; Föllmann W; Degen GH; Knopf HJ; Bolt HM; Golka K
Arch Toxicol; 2006 Jan; 80(1):45-52. PubMed ID: 16341845
[TBL] [Abstract][Full Text] [Related]
13. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.
Hata S; Miki Y; Fujishima F; Sato R; Okaue A; Abe K; Ishida K; Akahira J; Unno M; Sasano H
Life Sci; 2010 Mar; 86(11-12):393-401. PubMed ID: 20102722
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma.
Bergheim I; Wolfgarten E; Bollschweiler E; Hölscher AH; Bode C; Parlesak A
World J Gastroenterol; 2007 Feb; 13(7):997-1002. PubMed ID: 17373732
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
[TBL] [Abstract][Full Text] [Related]
17.
Lim SYM; Alshagga MA; Alshawsh MA; Ong CE; Pan Y
Drug Metab Pers Ther; 2021 Aug; 37(1):55-67. PubMed ID: 35146975
[TBL] [Abstract][Full Text] [Related]
18. Presence of cytochrome P450 enzymes in human CD34+ haematopoietic progenitor cells.
Kousalová L; Anzenbacherová E; Baranová J; Anzenbacher P; Skoumalová I; Vondraková J
Gen Physiol Biophys; 2004 Jun; 23(2):251-7. PubMed ID: 15696863
[TBL] [Abstract][Full Text] [Related]
19. Serum derived from ulcerative colitis mouse changes the metabolism of the fluorescent substrate by P450 depending on the degree of disease progression.
Yamamoto R; Muroi K; Imaishi H
Chem Biol Interact; 2018 Jun; 290():88-98. PubMed ID: 29842871
[TBL] [Abstract][Full Text] [Related]
20. CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.
Zia H; Murray GI; Vyhlidal CA; Leeder JS; Anwar AE; Bui MM; Ahmed AA
Int J Exp Pathol; 2015 Apr; 96(2):81-6. PubMed ID: 25670065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
